Stuart is Head of the Central and Eastern Europe, Middle East and Africa operating unit at SYNLAB, Europe’s leader in diagnostic laboratory services. Prior to this, he was CEO of SYNLAB UK & Ireland for four years. He was involved in establishing the UK business in 2010 and responsible for delivering a seven-fold increase in revenue growth over his tenure and an expansion into new NHS laboratory contracts, food & allergy, drug & alcohol, veterinary and oil & lubricant testing. Prior to joining SYNLAB, Stuart was an Investment Director at August Equity and before that he led 3i’s private equity investments into healthcare companies in the UK. Stuart also spent four years working in R&D strategy consulting for major pharmaceutical companies. He graduated with a BSc (Hons) in Immunology from the University of Edinburgh, a PhD in Immunology from Imperial College, London and with an MBA from INSEAD.